Literature DB >> 7972071

Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration.

C D Breder1, C Hazuka, T Ghayur, C Klug, M Huginin, K Yasuda, M Teng, C B Saper.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a cytokine that is responsible, in part, for several aspects of the acute-phase response to inflammation, including the generation of fever. TNF-alpha has direct effects on central nervous system neurons deep within the hypothalamus that are involved in producing the febrile response, but the blood-brain barrier prevents circulating TNF-alpha from having access to these sites. We therefore have hypothesized that TNF-alpha may be produced in the brain and used as a mediator in the cerebral components of the acute-phase response. We used in situ hybridization to determine the distribution of production of TNF-alpha mRNA in the mouse brain after systemic administration of lipopolysaccharide. During the initial phase of fever, hybridization was observed in perivascular cells and neurons in circumventricular organs, including the vascular organ of the lamina terminalis, median eminence, and area postrema, as well as along the ventral surface of the medulla; hybridization was also prominent over many cell in the meninges. During the late phase of the response, hybridization was observed over neurons in the pericircumventricular nuclei such as the anteroventral periventricular and arcuate nuclei of the hypothalamus and the nucleus of the solitary tract. TNF-alpha produced by a cascade of neurons within the brain may participate in the complex autonomic, neuroendocrine, metabolic, and behavioral responses to infection and inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972071      PMCID: PMC45237          DOI: 10.1073/pnas.91.24.11393

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Differential expression of somatostatin receptor subtypes in brain.

Authors:  C D Breder; Y Yamada; K Yasuda; S Seino; C B Saper; G I Bell
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

2.  Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

Authors:  C L Miller; A L Feldhaus; J W Rooney; L D Rhodes; C H Sibley; H Singh
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

3.  Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras.

Authors:  W F Hickey; K Vass; H Lassmann
Journal:  J Neuropathol Exp Neurol       Date:  1992-05       Impact factor: 3.685

4.  The structure of the mammalian area postrema.

Authors:  K R Brizzee; P M Klara
Journal:  Fed Proc       Date:  1984-12

5.  Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.

Authors:  D Pennica; J S Hayflick; T S Bringman; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Authors:  W L Xie; J G Chipman; D L Robertson; R L Erikson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Plasma catecholamines during E. coli bacteremia in conscious rats.

Authors:  S B Jones; M V Westfall; M M Sayeed
Journal:  Am J Physiol       Date:  1988-03

8.  Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system.

Authors:  C D Breder; M Tsujimoto; Y Terano; D W Scott; C B Saper
Journal:  J Comp Neurol       Date:  1993-11-22       Impact factor: 3.215

9.  Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

Authors:  E G Gutierrez; W A Banks; A J Kastin
Journal:  J Neuroimmunol       Date:  1993-09       Impact factor: 3.478

10.  Studies of endotoxin-induced decrease in lipoprotein lipase activity.

Authors:  M Kawakami; A Cerami
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  44 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 2.  Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?

Authors:  Ning Quan
Journal:  Mol Neurobiol       Date:  2008-06-19       Impact factor: 5.590

Review 3.  Pathways and mechanisms for cytokine signaling of the central nervous system.

Authors:  J Licinio; M L Wong
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 4.  Control of brain development, function, and behavior by the microbiome.

Authors:  Timothy R Sampson; Sarkis K Mazmanian
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 5.  Role of neurons in the control of immune defense.

Authors:  Casandra Hoffman; Alejandro Aballay
Journal:  Curr Opin Immunol       Date:  2019-05-19       Impact factor: 7.486

6.  Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.

Authors:  Hao Huang; Qian Hong; Hong-Ling Tan; Cheng-Rong Xiao; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-09-26       Impact factor: 6.150

Review 7.  Reprogramming the response to stroke by preconditioning.

Authors:  Susan L Stevens; Keri B Vartanian; Mary P Stenzel-Poore
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

Review 8.  Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma?

Authors:  Andrea Danese; Stephanie J Lewis
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

9.  Tetramethylpyrazine decreases hypothalamic glutamate, hydroxyl radicals and prostaglandin-E2 and has antipyretic effects.

Authors:  Chin-Hong Chang; Wu-Tein Huang; Cheng-Hsing Kao; Sheng-Hsien Chen; Cheng-Hsien Lin
Journal:  Inflamm Res       Date:  2013-03-23       Impact factor: 4.575

10.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.